Cadrenal Therapeutics, Common Stock Price Prediction

Intrinsic Valuation Low Real High 0.39 7.89 16.22 Details

2 Analysts Consensus Low Target High 2.73 3.00 3.33 Details

Earnings Estimates (0) Low Projected EPS High -2 -1.95 -1.89 Details

Cadrenal Therapeutics, After-Hype Price Prediction Density Analysis

Cadrenal Therapeutics, Estimiated After-Hype Price Volatility

Cadrenal Therapeutics, Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
1.31	8.33	1.24	0.02	10 Events / Month	3 Events / Month	In about 10 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
13.71	12.47	9.04	876.84   Notes

Cadrenal Therapeutics, Hype Timeline

Cadrenal Therapeutics, is currently traded for 13.71. The entity has historical hype elasticity of -1.24, and average elasticity to hype of competition of 0.02. Cadrenal is forecasted to decline in value after the next headline, with the price expected to drop to 12.47. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -9.04%, whereas the daily expected return is currently at 1.31%. The volatility of related hype on Cadrenal Therapeutics, is about 46277.78%, with the expected price after the next announcement by competition of 13.73. About 34.0% of the company shares are held by company insiders. The company recorded a loss per share of 6.73. Cadrenal Therapeutics, had not issued any dividends in recent years. The entity had 1:15 split on the 20th of August 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Cadrenal Therapeutics, Basic Forecasting Models to cross-verify your projections.

Cadrenal Therapeutics, Related Hype Analysis

Cadrenal Therapeutics, Additional Predictive Modules

Most predictive techniques to examine Cadrenal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cadrenal using various technical indicators. When you analyze Cadrenal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Cadrenal Therapeutics, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cadrenal Therapeutics, Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cadrenal Therapeutics, based on analysis of Cadrenal Therapeutics, hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Cadrenal Therapeutics, depends on current market conditions and Cadrenal Therapeutics,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cadrenal Therapeutics, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cadrenal Therapeutics,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cadrenal Therapeutics,'s future price predictability will typically decrease when Cadrenal Therapeutics,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cadrenal Therapeutics, Common often depends not only on the future outlook of the potential Cadrenal Therapeutics,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cadrenal Therapeutics,'s indicators that are reflective of the short sentiment are summarized in the table below.

When running Cadrenal Therapeutics,'s price analysis, check to measure Cadrenal Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cadrenal Therapeutics, is operating at the current time. Most of Cadrenal Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Cadrenal Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cadrenal Therapeutics,'s price. Additionally, you may evaluate how the addition of Cadrenal Therapeutics, to your portfolios can decrease your overall portfolio volatility.